(S)-N4-(tert-butoxy)-N1-((S)-3-(4-fluorophenyl)-1-((naphthalen-1-ylmethyl)amino)-1-oxopropan-2-yl)-2-(3-phenylpropanamido)succinamide

ID: ALA4516988

PubChem CID: 91824176

Max Phase: Preclinical

Molecular Formula: C37H41FN4O5

Molecular Weight: 640.76

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)ONC(=O)C[C@H](NC(=O)CCc1ccccc1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)NCc1cccc2ccccc12

Standard InChI:  InChI=1S/C37H41FN4O5/c1-37(2,3)47-42-34(44)23-32(40-33(43)21-18-25-10-5-4-6-11-25)36(46)41-31(22-26-16-19-29(38)20-17-26)35(45)39-24-28-14-9-13-27-12-7-8-15-30(27)28/h4-17,19-20,31-32H,18,21-24H2,1-3H3,(H,39,45)(H,40,43)(H,41,46)(H,42,44)/t31-,32-/m0/s1

Standard InChI Key:  DDEQIWLWJUDFKG-ACHIHNKUSA-N

Molfile:  

 
     RDKit          2D

 47 50  0  0  0  0  0  0  0  0999 V2000
    7.7014  -22.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4132  -22.2004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1251  -22.6090    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4132  -21.3790    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.9896  -22.2004    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.9896  -21.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2777  -20.9663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7014  -20.9663    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2777  -20.1450    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5700  -19.7364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5752  -18.9140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8642  -18.5014    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1514  -18.9142    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1540  -19.7397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8656  -20.1445    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7014  -23.4303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9896  -23.8430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9896  -24.6643    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.2777  -23.4303    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5700  -23.8430    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8582  -23.4303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1464  -23.8430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8582  -22.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1437  -23.0176    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8369  -22.2004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5488  -22.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2606  -22.2004    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5488  -23.4303    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.9683  -22.6090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6801  -22.2004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1027  -21.3829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3859  -20.9703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6774  -21.3847    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1022  -22.2051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3921  -22.6116    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3921  -23.4286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1016  -23.8400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8125  -23.4244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8089  -22.6087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8369  -21.3790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5488  -20.9663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2604  -21.3816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9676  -20.9695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9680  -20.1473    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2553  -19.7389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5469  -20.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6793  -19.7378    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  1  5  1  0
  5  6  1  0
  6  7  1  0
  6  8  2  0
  7  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  1 16  1  6
 16 17  1  0
 17 18  2  0
 17 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 21 23  1  0
 21 24  1  0
  3 25  1  0
 25 26  1  0
 26 27  1  0
 26 28  2  0
 27 29  1  0
 29 30  1  0
 30 35  2  0
 34 31  2  0
 31 32  1  0
 32 33  2  0
 33 30  1  0
 34 35  1  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
 25 40  1  1
 40 41  1  0
 41 42  2  0
 42 43  1  0
 43 44  2  0
 44 45  1  0
 45 46  2  0
 46 41  1  0
 44 47  1  0
M  END

Associated Targets(Human)

PSMB8 Tclin Proteasome subunit beta type-8 (743 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PBMC (10003 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PSMB5 Tclin Proteasome Macropain subunit MB1 (2451 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 640.76Molecular Weight (Monoisotopic): 640.3061AlogP: 4.68#Rotatable Bonds: 14
Polar Surface Area: 125.63Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.41CX Basic pKa: CX LogP: 4.89CX LogD: 4.86
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.15Np Likeness Score: -0.56

References

1. Schiffrer ES, Sosič I, Šterman A, Mravljak J, Raščan IM, Gobec S, Gobec M..  (2019)  A focused structure-activity relationship study of psoralen-based immunoproteasome inhibitors.,  10  (11): [PMID:32952997] [10.1039/C9MD00365G]
2. Zhan W,Singh PK,Ban Y,Qing X,Ah Kioon MD,Fan H,Zhao Q,Wang R,Sukenick G,Salmon J,Warren JD,Ma X,Barrat FJ,Nathan CF,Lin G.  (2020)  Structure-Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides.,  63  (21): [PMID:33095579] [10.1021/acs.jmedchem.0c01520]

Source